Lyon
France
28
2026-05-21
19
2026-03-10
These are the the leading inventors for applications assigned to Sanofi Pasteur:
Sanofi Pasteur based in Lyon, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
ZIKA VIRUS VACCINE
#2 | 2024-04-25 ✅ Patent 12,569,549 granted on 2026-03-10FLAVIVIRUS VACCINE
#3 | 2024-01-25 ✅ Patent 12,496,335 granted on 2025-12-16ZIKA VIRUS VACCINE
#4 | 2023-12-14Liposomes Containing TLR4 Agonist, Preparation and Uses Thereof
#5 | 2019-07-04Vaccine Compositions
#6 | 2019-01-17 ✅ Patent 10,577,398 granted on 2020-03-03Multimerization of recombinant protein by fusion to a sequence from lamprey
#7 | 2018-10-04 ✅ Patent 10,772,946 granted on 2020-09-15Immunogenic compositions against
#8 | 2017-07-27 ✅ Patent 10,144,940 granted on 2018-12-04Method for producing type B antigens
#9 | 2016-04-07 ✅ Patent 9,937,252 granted on 2018-04-10Induction of cross-reactive cellular response against rhinovirus antigens
#10 | 2015-10-01VACCINATION AGAINST JAPANESE ENCEPHALITIS, MEASLES, MUMPS AND RUBELLA
#11 | 2014-06-26Immuno-Adjuvant Emulsion
#12 | 2014-02-06 ✅ Patent 9,028,839 granted on 2015-05-12Stabilizing excipient for inactivated whole virus vaccine
#13 | 2013-01-31Stabilizer and Vaccine Composition Comprising One or More Live Attenuated Flaviviruses
#14 | 2012-02-23 ✅ Patent 9,019,496 granted on 2015-04-28Method for estimating the amount of entities deposited on microparticles in suspension in a solution, associated device and use of said device
#15 | 2011-08-04 ✅ Patent 8,697,353 granted on 2014-04-15Immunization compositions and methods
#16 | 2011-04-07 ✅ Patent 8,557,253 granted on 2013-10-15Stabilizing excipient for inactivated whole virus vaccine
#17 | 2011-01-20 ✅ Patent 8,506,971 granted on 2013-08-13Method for adjuvanting lipopolysaccharide (LPS) of gram-negative bacteria
#18 | 2010-12-30 ✅ Patent 9,132,181 granted on 2015-09-15Meningococcal vaccine based on lipooligosaccharide (LOS) originating from modified strains of immunotype L6
#19 | 2010-11-18Detoxification method for lipopolysaccharide (LPS) or lipid A of gram-negative bacteria
#20 | 2010-10-14 ✅ Patent 8,961,997 granted on 2015-02-24Method for purifying the rabies virus
#21 | 2010-05-06Polypeptide Recognized by Anti HIV-1 GP41 Antibodies Isolated from Highly HIV-1 Exposed, Non Infected Women
#22 | 2010-01-21 ✅ Patent 8,142,795 granted on 2012-03-27Stabilizer and vaccine composition comprising one or more live attenuated flaviviruses
#23 | 2009-09-17 ✅ Patent 8,551,527 granted on 2013-10-08Process for stabilizing an adjuvant containing vaccine composition
#24 | 2009-04-23VACCINE COMPOSITION FOR THE PREVENTION OF CMV INFECTION
#25 | 2009-04-09 ✅ Patent 9,005,623 granted on 2015-04-14Flu virus hemagglutinin specific monoclonal antibodies
#26 | 2009-03-26 ✅ Patent 7,871,807 granted on 2011-01-18Method for producing the flu virus
#27 | 2008-01-17 ✅ Patent 7,718,357 granted on 2010-05-18Method of immunization against the 4 dengue serotypes
#28 | 2007-01-18 ✅ Patent 8,703,095 granted on 2014-04-22Immuno-adjuvant emulsion
Also check out Sanofi Pasteur's (Lyon, France) applicant profile with 4 patent applications submitted.
7109 ⎘